Annual Revenue
$51.13 M
-$80.70 M-61.21%
31 December 2023
Summary:
Repare Therapeutics annual revenue is currently $51.13 million, with the most recent change of -$80.70 million (-61.21%) on 31 December 2023. During the last 3 years, it has risen by +$51.00 million (+37776.30%). RPTX annual revenue is now -61.21% below its all-time high of $131.83 million, reached on 31 December 2022.RPTX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
N/A
30 September 2024
Summary:
Repare Therapeutics quarterly revenue is not available.RPTX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
N/A
30 September 2024
Summary:
Repare Therapeutics TTM revenue is not available.RPTX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPTX Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -61.2% | - | - |
| 3 y3 years | +10000.0% | - | - |
| 5 y5 years | - | - | - |
RPTX Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -61.2% | >+9999.0% | ||||
| 5 y | 5 years | -61.2% | >+9999.0% | ||||
| alltime | all time | -61.2% | >+9999.0% |
Repare Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $1.07 M(-98.0%) | $68.68 M(-29.8%) |
| Mar 2024 | - | $52.40 M(+301.7%) | $97.86 M(+91.4%) |
| Dec 2023 | $51.13 M(-61.2%) | $13.05 M(+504.3%) | $51.13 M(-9.2%) |
| Sept 2023 | - | $2.16 M(-92.9%) | $56.28 M(-66.2%) |
| June 2023 | - | $30.25 M(+432.7%) | $166.67 M(+21.6%) |
| Mar 2023 | - | $5.68 M(-68.8%) | $137.10 M(+4.0%) |
| Dec 2022 | $131.83 M | $18.20 M(-83.8%) | $131.83 M(+9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $112.55 M(>+9900.0%) | $120.51 M(+1362.1%) |
| June 2022 | - | $679.00 K(+66.4%) | $8.24 M(+5.1%) |
| Mar 2022 | - | $408.00 K(-94.1%) | $7.84 M(+3.2%) |
| Dec 2021 | $7.60 M(+5529.6%) | $6.88 M(+2373.7%) | $7.60 M(+785.8%) |
| Sept 2021 | - | $278.00 K(-0.4%) | $858.00 K(+47.9%) |
| June 2021 | - | $279.00 K(+68.1%) | $580.00 K(+92.7%) |
| Mar 2021 | - | $166.00 K(+23.0%) | $301.00 K(+123.0%) |
| Dec 2020 | $135.00 K | $135.00 K | $135.00 K |
FAQ
- What is Repare Therapeutics annual revenue?
- What is the all time high annual revenue for Repare Therapeutics?
- What is Repare Therapeutics annual revenue year-on-year change?
- What is the all time high quarterly revenue for Repare Therapeutics?
- What is the all time high TTM revenue for Repare Therapeutics?
What is Repare Therapeutics annual revenue?
The current annual revenue of RPTX is $51.13 M
What is the all time high annual revenue for Repare Therapeutics?
Repare Therapeutics all-time high annual revenue is $131.83 M
What is Repare Therapeutics annual revenue year-on-year change?
Over the past year, RPTX annual revenue has changed by -$80.70 M (-61.21%)
What is the all time high quarterly revenue for Repare Therapeutics?
Repare Therapeutics all-time high quarterly revenue is $112.55 M
What is the all time high TTM revenue for Repare Therapeutics?
Repare Therapeutics all-time high TTM revenue is $166.67 M